We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01044446
First Posted: January 7, 2010
Last Update Posted: August 10, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Chow Kai Ming, Chinese University of Hong Kong
  Purpose
The objective of the present study is to evaluate the a prior hypothesis that treatment with icodextrin during acute peritonitis would improve the treatment outcomes of peritonitis complicating peritoneal dialysis. The safety and effectiveness of icodextrin for decreasing glucose exposure, extent and severity of peritonitis will be evaluated in the setting of acute peritonitis complicating peritoneal dialysis among patients who are not receiving icodextrin.

Condition Intervention Phase
Peritonitis Drug: Icodextrin Drug: glucose-based peritoneal dialysate Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients

Resource links provided by NLM:


Further study details as provided by Chow Kai Ming, Chinese University of Hong Kong:

Primary Outcome Measures:
  • peritoneal dialysate total white cell count on day 3 of acute peritonitis [ Time Frame: day 3 ]

Secondary Outcome Measures:
  • need of additional hypertonic exchanges, ultrafiltration volumes according to patient diary, fluid control as denoted by changes in body weight, and the timing of peritonitis resolution [ Time Frame: within the period of peritonitis treatment ]

Enrollment: 56
Study Start Date: January 2010
Study Completion Date: April 2013
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Icodextrin
peritoneal dialysate
Drug: Icodextrin
one exchange daily
Active Comparator: Glucose-based dialysate
peritoneal dialysate
Drug: glucose-based peritoneal dialysate
original exchange frequency

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • aged 18 or older on peritoneal dialysis, who develop clinical evidence of peritonitis
  • stable peritoneal dialysis with Baxter connection system
  • willingness to give written consent and comply with the study protocol

Exclusion Criteria:

  • already on icodextrin dialysate prior to acute presentation with peritonitis
  • known allergy or hypersensitivity to icodextrin, starch or have a glycogen storage disease
  • participation in another interventional study within last 30 days of randomization
  • history of a psychological illness or condition that would interfere with the patient's ability to understand the requirement of the study and/or comply with the study procedures
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01044446


Locations
Hong Kong
Prince of Wales Hospital, Chinese University of Hong Kong
Shatin, New Territories, Hong Kong, SAR
Sponsors and Collaborators
Chinese University of Hong Kong
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Chow Kai Ming, Associate Consultant, Chinese University of Hong Kong
ClinicalTrials.gov Identifier: NCT01044446     History of Changes
Other Study ID Numbers: CRE-2009.481
First Submitted: January 6, 2010
First Posted: January 7, 2010
Last Update Posted: August 10, 2016
Last Verified: August 2016

Keywords provided by Chow Kai Ming, Chinese University of Hong Kong:
peritoneal dialysis
peritonitis
CAPD
end-stage renal disease
peritonitis outcome and ultrafiltration

Additional relevant MeSH terms:
Peritonitis
Intraabdominal Infections
Infection
Peritoneal Diseases
Digestive System Diseases
Dialysis Solutions
Icodextrin
Pharmaceutical Solutions